Ethyol(R) Introduced in Europe.WEST CONSHOHOCKEN Conshohocken (kŏn'shəhŏk`ən), industrial borough (1990 pop. 8,064), Montgomery co., SE Pa., on the Schuylkill River; inc. 1850. Food, fabricated metals, and electronic products are produced., Penn.--(BUSINESS WIRE)--April 17, 1995--U.S. Bioscience Inc. (AMEX:UBS) announced that the first introduction for sale of Ethyol(R) (amifostine amifostine /am·i·fos·tine/ (am?i-fos´ten) a chemoprotectant used to prevent renal toxicity in cisplatin chemotherapy.), a selective cytoprotective cytoprotective /cy·to·pro·tec·tive/ (si?to-pro-tek´tiv) 1. protecting cells from noxious chemicals or other stimuli. 2. an agent that so protects. agent, occurred in Germany and that the product will also be available soon in the United Kingdom. Ethyol is indicated for the reduction of neutropenia neutropenia /neu·tro·pe·nia/ (noo?tro-pe´ne-ah) diminished number of neutrophils in the blood.neu·tro·pe·ni·a (n   tr-related infection resulting from the use of the combination regimen cyclophosphamide cyclophosphamide /cy·clo·phos·pha·mide/ (-fos´fah-mid) a cytotoxic alkylating agent of the nitrogen mustard group; used as an antineoplastic, as an immunosuppressant to prevent transplant rejection, and to treat some diseases characterized by abnormal immune function. and cisplatin (two anti-cancer agents) in patients with advanced ovarian carcinoma. This launch follows the European Union's Committee for Proprietary Medicinal Products' recommendation for approval in September 1994, and the subsequent clearance for marketing in Germany. To date, Ethyol has also been cleared for marketing in the United Kingdom, France, Spain and Luxembourg. Schering-Plough introduced Ethyol in Germany on April 15 and plans to launch in the United Kingdom in May. An affiliated company of Schering-Plough Corp. has exclusive marketing rights to Ethyol in the countries comprising the European union and the European Free Trade Association. Schering-Plough plans to launch in the other approved markets in Europe as soon as local pricing and reimbursement approvals are gained. Based in West Conshohocken, U.S. Bioscience Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS. CONTACT: U.S. BIOSCIENCE INC. Robert I. Kriebel, 610/832-0570 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion